{"id":"W2067395077","doi":"10.2147/ijwh.s47357","title":"Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations","year":2014,"lang":"en","type":"review","venue":"International Journal of Women s Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Oncology; Breast cancer; Metastatic breast cancer; Internal medicine; Disease; Clinical trial; Human Epidermal Growth Factor Receptor 2; Epidermal growth factor receptor; Cancer; Targeted therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009464506,0.0004621084,0.001402913,0.001675707,0.0002245895,0.001042834,0.0008833699,0.00136318,0.002534311],"category_scores_gemma":[0.001221507,0.0002211577,0.0005536162,0.002170032,0.0003717536,0.001231209,0.0004341241,0.001415729,0.0009376174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006259069,"about_ca_system_score_gemma":0.00129484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001188899,"about_ca_topic_score_gemma":0.002802085,"domain_scores_codex":[0.9997026,0.00007539489,0.00004710242,0.00003569086,0.0001169869,0.00002212139],"domain_scores_gemma":[0.9995924,0.0002324441,0.00005779957,0.000008396079,0.00008650658,0.00002247563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007979511,0.00005539637,0.0001041171,0.02083321,0.00009515823,0.0002892233,0.00005189615,0.0002875035,0.000780963,0.003026537,0.0226358,0.9517604],"study_design_scores_gemma":[0.00005212662,0.0001528007,0.0008604039,0.008171167,0.0001996265,0.001999373,0.00008411449,0.000115516,0.0003687752,0.002538705,0.9854383,0.00001906186],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008918338,0.9990335,0.00003737721,0.0003564788,0.00007691902,0.000003030533,0.00000589801,0.000001636621,0.0003960392],"genre_scores_gemma":[0.0005296286,0.9988562,0.00008309595,0.0001915571,0.00008873264,0.000004424434,0.000006928034,5.270739e-7,0.0002390019],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002534311,"threshold_uncertainty_score":0.008478105,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1159475993364599,"score_gpt":0.5152411216543599,"score_spread":0.3992935223179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}